Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment. [electronic resource]
Producer: 20091015Description: 1547-56 p. digitalISSN:- 1473-5571
- Adenine -- adverse effects
- Adult
- Anti-HIV Agents -- adverse effects
- Antiretroviral Therapy, Highly Active -- adverse effects
- CD4 Lymphocyte Count
- Cardiovascular Diseases -- chemically induced
- Deoxycytidine -- adverse effects
- Dideoxynucleosides -- adverse effects
- Double-Blind Method
- Emtricitabine
- Female
- HIV Infections -- drug therapy
- HIV-1 -- genetics
- Humans
- Lamivudine -- adverse effects
- Lopinavir
- Male
- Organophosphonates -- adverse effects
- Pyrimidinones -- adverse effects
- RNA, Viral -- blood
- Ritonavir -- adverse effects
- Tenofovir
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.